Study Evaluating Safety, Tolerability, and Metabolism of Niraparib — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib — Stella

Recruiting

Back to Ovarian Cancer trials

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(2 sites)

United States

Broward Health, Fort Lauderdale, Florida

University of Miami, Miami, Florida

Key details

Phase

Post-approval monitoring

Sponsor

University of Miami

Collaborators

GlaxoSmithKline

Enrollment target

~70 participants

Started

June 2026

Primary completion

June 2029

Age range

18 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov